Transjugular leadless pacemaker implantation after transcatheter tricuspid valve replacement with a biological prosthetic valve: a case report

European Heart Journal - Case Reports

24 November 2025
Organised by: Logo
ESC Journals ARRHYTHMIAS AND DEVICE THERAPY Device Therapy VALVULAR, MYOCARDIAL, PERICARDIAL, PULMONARY, CONGENITAL HEART DISEASE Valvular Heart Disease

Abstract

AbstractBackground

Transcatheter tricuspid valve replacement (TTVR) is an emerging therapy for patients with severe tricuspid regurgitation who are not candidates for surgery. Post-procedural atrioventricular (AV) block may necessitate permanent pacing, but traditional transvenous systems are often contraindicated in the setting of a tricuspid prosthetic valve. Leadless pacemakers represent a valuable alternative, though anatomic changes after valve implantation may challenge standard transfemoral delivery.

Case summary

We report the case of an 82-year-old woman who underwent successful TTVR for severe tricuspid regurgitation. Three days later, she developed complete AV block requiring permanent pacing. Attempts to implant a leadless pacemaker via the right femoral vein failed due to altered tricuspid valve orientation. A transjugular approach enabled effective deployment of the device on the interventricular septum.

Discussion

High-degree AV block is not an infrequent complication occurring after TTVR. Pacing strategies to spare further valve disturbances are mainly represented by single-lead pacing via the coronary sinus and leadless cardiac pacemaker implantation. An individualized approach based on anatomical considerations is essential in the context of complex structural heart interventions.

Conclusion

The transjugular approach can serve as a reliable alternative for leadless pacemaker delivery in patients with tricuspid biological prosthetic valve, offering favourable curvature and access in anatomically challenging cases.

Contributors

ESC 365 is supported by